Shionogi & Co Equity 2024

Shionogi & Co Aktienanalyse

What does Shionogi & Co do?

The company Shionogi & Co Ltd is a Japanese pharmaceutical company based in Osaka. It was founded in 1878 and has since become a significant player in the industry. It currently employs over 6,000 employees worldwide and is listed on the Tokyo Stock Exchange. Shionogi is divided into several business segments that offer different products and services. The largest segment is the pharmaceutical division, which specializes in the development and marketing of drugs. The company has strong expertise in infectious diseases, pain management, and oncology, and operates in many countries worldwide. One flagship product is the antibiotic Cefditoren, used to treat various bacterial infections. In addition to the pharmaceutical division, Shionogi is also active in other areas. For example, the company offers diagnostic and laboratory services, operating multiple labs in Japan and other countries. Another business segment is the production and marketing of nutritional supplements, sold in Japan, China, and the USA. Shionogi's business model is based on extensive research and development, as well as strong brand positioning. The company invests a significant portion of its revenue each year in the research and development of new drugs and better treatment options for existing diseases. Thanks to the high quality of its products and strong brand, the company has a loyal customer base. In recent years, Shionogi has focused on international expansion opportunities and has expanded its activities in various regions. For example, it has partnered with US pharmaceutical company Purdue Pharma to develop and market a novel pain medication. Shionogi's annual revenue is around 1.5 billion euros. The company is particularly strong in Japan and other Asian countries, but is also active in the US and Europe. In the coming years, Shionogi aims to further expand its international business and solidify its position as a significant player in the industry. Key focuses will be on the launch of new products and finding treatments for previously incurable diseases. Overall, Shionogi is an innovative and successful company that utilizes its expertise in the pharmaceutical industry in various ways. With its dedicated employees and strong brand, it will continue to play an important role in the industry. Shionogi & Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Shionogi & Co's Equity

Shionogi & Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Shionogi & Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Shionogi & Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Shionogi & Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Shionogi & Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Shionogi & Co stock

What is the equity of Shionogi & Co this year?

Shionogi & Co has equity of 1.24 T JPY this year.

What was the equity of Shionogi & Co compared to the previous year?

The equity of Shionogi & Co has increased/decreased by 26.61% increased compared to the previous year.

What impact does a high equity have on investors of Shionogi & Co?

A high equity is advantageous for investors of Shionogi & Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Shionogi & Co?

A low equity can be a risk for investors of Shionogi & Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Shionogi & Co affect the company?

An increase in equity of Shionogi & Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Shionogi & Co affect the company?

A reduction in equity of Shionogi & Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Shionogi & Co?

Some factors that can affect the equity of Shionogi & Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Shionogi & Co so important for investors?

The equity of Shionogi & Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Shionogi & Co take to change the equity?

To change equity, Shionogi & Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Shionogi & Co pay?

Over the past 12 months, Shionogi & Co paid a dividend of 170 JPY . This corresponds to a dividend yield of about 2.56 %. For the coming 12 months, Shionogi & Co is expected to pay a dividend of 183.81 JPY.

What is the dividend yield of Shionogi & Co?

The current dividend yield of Shionogi & Co is 2.56 %.

When does Shionogi & Co pay dividends?

Shionogi & Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Shionogi & Co?

Shionogi & Co paid dividends every year for the past 23 years.

What is the dividend of Shionogi & Co?

For the upcoming 12 months, dividends amounting to 183.81 JPY are expected. This corresponds to a dividend yield of 2.76 %.

In which sector is Shionogi & Co located?

Shionogi & Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shionogi & Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shionogi & Co from 12/1/2024 amounting to 85 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Shionogi & Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Shionogi & Co in the year 2023?

In the year 2023, Shionogi & Co distributed 150 JPY as dividends.

In which currency does Shionogi & Co pay out the dividend?

The dividends of Shionogi & Co are distributed in JPY.